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This paper reports an evaluation of the IL-Phoenix Chemistry/
Electrolyte Analyser; the evaluation was carried out in accordance
with internationally recognized guidelines. The evaluation was
performed in three steps: evaluation in routine conditions;
assessment of interferences; and study of practicability. Seven
constituents were studied under routine working conditions.
Within-run imprecision rangedfrom 0"6% (CV) for chloride to
3.1% (CV) for glucose. Between-run imprecision ranged from
0"9% for sodium to 6"0% (CV) for urea. Sample-related carry-
over was not significant. The relative inaccuracy was acceptable;
drift was negligible; linearity was agreed with the range showed by
the supplier. Haemoglobin produced negative interferences with
sodium and chloride. Turbidity interfered negatively with sodium,
chloride, potassium and total calcium, andpositively with glucose.
Bilirubin showed a negative interference with sodium, chloride and
creatinine.
Introduction
The IL-Phoenix is an eight-channel fully automated
system that can analyse serum, plasma, urine and
cerebrospinal fluid (CSF) samples. The IL-Phoenix
utilizes potentiometric, spectrophotometric and ampero-
metric techniques for in vitro measurements on stat
samples, as well as routine runs.
The evaluation reported here was done according to the
guidelines of the Comisidn de Instrumentacidn de la
Sociedad Espafiola de Qufmica Clfnica [1]; the European
Committee for Clinical Laboratory Standards [2]; and
the Comission de Validation de Tchniques de la Socifit
Franaise de Biologie Clinique [3]. The evaluation
included an investigation ofwithin-run and between-run
imprecisions, sample-related carry-over, method com-
parison using patient specimens, drift, linearity and
detection limit. The effects of an in vitro haemolysis,
turbidity and bilirubin were also studied. The analyser
was evaluated for system performance, the analytical
procedure control, and ease of maintenance.
Materials and methods
Instrument
The IL-Phoenix (Instrumentation Laboratory, Lex-
ington, Massachussetts, USA) is a fully automated eight-
channel system that analyses serum, plasma, urine or
CSF samples. The analyser utilizes potentiometric spec-
trophotometric and amperometric techniques for in vitro
measurements on stat samples, as well as routine runs.
The analyser can be connected to a compatible data
management system for retrieval and processing of
patient datal The IL-Phoenix is available in two models:
(1) The Model 900 is used for analysis of sodium,
potassium, chloride, glucose, urea, creatinine, total
calcium and total carbon dioxide (TCO2).
(2) The Model 905 performs as the 900, except that it
measures total protein rather than TCO2.
The evaluation was done with a Model 900; an examin-
ation of TCO measurement was not included. Its
performance with urine and CSF samples was not
evaluated.
The IL-Phoenix can calculate osmolality, urea/creatinine
ratio, creatinine clearance and anion gap. In addition,
both models feature automatic linearity extension
(ALEX), in which half the normal sample volume is
aspirated ifthe sample results are outside the linear range
of the analyser (except for TCO). The aspirated sample
volume is diluted with an equal volume of distilled water.
A keyboard is used to specify the tests to be run, to start
the analysis and to perform functions related to the tests;
a colour monitor displays the tests to be run for each
sample or retrieves data from previously run test and
other performance functions. Up to three routine runs (30
samples/run) can be displayed in the monitor. Test
results are printed automatically or upon request by the
analyser dot-matrix printer.
The IL-Phoenix can handle 75 samples per hour, and up
to 600 tests per hour. Stat tests are completed in min.
The Model 900 requires 97 tl of sample for an eight-test
panel (65 tl if Model 905).
A wide range of menu-selectable tests are available to
confirm the status ofanalyser components. Analyser state
messages, such ’Analysing’ and ’Calibrating’, are dis-
played. In addition, the analyser can display several
attention messages.
Integrated fluidic circuits (manifolds) enable the use of
short fluid paths for easier maintenance and avoid the
leakage or mixture of fluids. Sodium, potassium, chloride
and total calcium tests are run in the same manifold;
another one is for glucose and urea; there is a third one for
creatinine.
The working temperature is 37C for creatinine tests;
31C for gluocse and urea tests; and room temperature
for the others.
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Methods
The following methods are used:
(1) Sodium: ion selective electrode (Na glass).
(2) Potassium: ion selective electrode (neutral carrier
membrane).
(3) Chloride: ion selective electrode (Ag/AgC1 pellet).
(4) Total calcium: ion selective electrode (neutral carrier
membrane).
(5) Glucose: immobilized glucose oxidase (EC 1.1.3.4)
+ amperometric oxygen electrode (fixed time
reaction).
(6) Urea: immobilized urease (EC 3.5.1.5) + ammo-
nium selective electrode (fixed time reaction).
(7) Creatinine: absorbance (Jaffe reaction) (rate).
The enzymes used in the glucose and urea assays are
immobilized on the internal face of a nylon tube and the
sampies flow through it.
Specimens and control solutions
Forty serum samples, collected in vacuum tubes, were
analysed. The control sera used were Control Key-trol
Normal (ITC Diagnostics, lot No. 5020-6); and Control
Key-trol Anormal (ITC Diagnostics, lot No. 5021-7). A
sera pool from healthy individuals for the interferences
studies.
Reagents
Reagents, buffers and calibrators are available exclus-
ively from Instrumentation Laboratory. Reagents and
buffers used were: IL Test ISE Buffer; IL Test ISE
Reference; IL Test Glucose/Urea Buffer, IL Test Creat-
inine. The calibrators used were: Surecal Calibrator (lot
No. L0300089); Surecal 2 Calibrator (lot No. L0400128);
Surecal 3 Calibrator (lot No. L0300090); Surecal 4
Calibrator (lot No. L0400117); Surecal 5 Calibrator (lot
No. L0300082); Bilirubin Sigma B-4126 was used for the
interferences studies. The Technicon CHEM-1 was used
for the method comparison study.
Evaluation protocol
Imprecision
To study the within-run imprecision, 30 samples of
control sera were tested at two levels in the same run. To
evaluate the between-run imprecision, a further 20
samples at each of two levels were distributed in 20
different runs.
Sample-related carry-over
The carry-over caused by the sample was studied
according to a model of Broughton [4]. Following an
alternative permutation order, two control samples with
different concentration were tested. Three high concen-
tration specimens, followed by three low concentration
specimens, were processed 20 times and the carry-over
ratio k was calculated. A mean for 20 determinations ofk
was obtained. The carry-over ratio c according to a model
of Bennet et al. [5] was also calculated.
Reagent-related carry-over
Because of the performance mechanism of the IL-
Phoenix the reagent-related carry-over was not studied.
Method comparison
Forty human sera (in different analytical series), covering
the pathophysiological analytical range for each of the
seven analytes, were analysed in parallel with the IL-
Phoenix and the Technicon CHEM-1. The results
obtained from both analysers were compared. The
statistical evaluation was done by a non-parametric
method according to Passing and Bablok [6,7].
A control (within the physiological range for each
evaluated component) was assayed once immediately
after calibration, and at eight and 12 hours after
calibration. The study was repeated three times and the
means of the obtained values were compared by the non-
parametric test of Wilcoxon.
Linearity
Six decreasing dilutions of a serum for each evaluated
analyte was prepared. Three aliquots of each dilution
were assayed on three different days, to obtain nine sets of
results.
Detection limit
The detection limit was taken as the mean of the least
quantity or concentration of a substance that can be
distinguished, with a given probability, from a reaction
blank carried out under the same conditions. This ideal
reaction blank was carried out using distilled water. The
smallest concentrations of the analytes were obtained in
three series of 10 determinations. The analytes studied
were glucose, urea and creatinine.
Imprecision and inaccuracy of the sample dilution system (Alex)
Twenty samples of a pool with higher concentrations
than the linear range of the analyser, for each evaluated
analyte, were tested. Results were compared with the
corresponding ones obtained by testing 20 samples of the
same source solution diluted manually, according to a
Student test for paired data.
Interferences
The effects of in vitro haemolysis, turbidity and bilirubin
were evalauted on seven tests, according to the protocol of
the Socit Franaise de Biologie Clinique [3] and the
NCCLS [8]. These potential interferents were studied by
overloading a human sera pool with increasing concen-
trations ofhaemoglobin (up to 210 mol), total bilirubin
(up to 500 tmol/1) and triglycerides (up to 8"5 mmol/1).
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Table 1. Imprecision.
Within-run"
Test Y CV (%)
Between-run+ +
cv (%)
Total calcium H 3"01 0"9 (1.5)
(mmol/1) L 1"87 1"3 (1"5)
Chloride H 117 0"7 (1"5)
(mmol/1) L 84 0"6 (1"5)
Creatinine H 774 0"9 (2"0)
(mol/1) L 66 2"9 (3"5)
Glucose H 16.1 1.0 "0)
(mmol/1) L 3"3 3"1 (2"5)
Potassium H 7"4 0"9 1"5)
(mmol/1) L 3"1 1"0 (2"0)
Sodium H 152 0"7 (1"0)
(mmol/1) L 109 0-7 (1"0)
Urea H 18"6 1"2 (2"0)
(mmol/1) L 3"3 1.3 (4.0)
2"94
1"80
116
81
755
64
16"2
3"3
7"3
3.1
150
108
17.8
3.4
2-0
2"0
2"0
2"0
2"0
5"0
2"6
3"0
1"2
2"6
0"9
2"0
3"0
6"0
(1.6)
(1.6)
(1.6)
(1.6)
(2.4)
(4.0)
(1.6)
(1.6)
(2.0)
(1.0)
(1.2)
(4.8)
Figures in brackets are target values derived and described in reference [3].
The value obtained for each specimen and test was
calculated as a percentage of the original concentration
(before overloading) and expressed graphically.
Results and discussion
Imprecision
Table summarizes the results of the within-run and
between-run imprecision studies. The acceptable coef-
ficients of variation (CV %) are expressed according to
the protocol ofValidation de Techniques [3]. Within-run
imprecision was acceptable for total calcium, chloride,
creatinine, potassium, sodium and urea; for glucose
within-run CV and between-run imprecision results, the
obtained CVs were higher but near the tolerable limit.
Sample-related carry-over
The results of the study of the sample-related carry-over
are shown in table 2. The mean of the k and c values were
less than 2% (except the c value for urea).
Method comparison with patient specimens
The results ofthe relative inaccuracy study for each ofthe
evaluated analytes are shown in table 3. A proportional
difference (p < 0"05) was detected between the two
analytical methods for creatinine. There were also
proportional and constant differences (p < 0"05) for total
calcium. For the remaining tests, the results reflected a
good degree of agreement with the comparison instru-
ment although r coefficients for sodium and chloride were
slightly less than 0"800.
Drift
Drift was studied by processing the same specimen
immediately after the calibration and 12 hours later, and
the results were compared according to a non-parametric
test of Wilcoxon for paired data. During the test, the
specimen was stored at 4C. The drift was negligible; the
results are shown in table 4.
Linearity
Linearity was within the range specified by the manufac-
turer; results are shown in table 5.
Detection limit
For a risk o 5% and large samples (N-> 30), the upper
limit of the blank confidence interval was calculated as
being : + 2S. This value that corresponds with the
detection limit for the given risk see table 6.
Table 2. Sample-related carry-over.
Sequence: H1 H2- H3- L1 L2- L3
H=High, L=Low, n= 20
L1 L3
Broughton: K(%) x 100
H3- L3
L1 L3 Bennett: C(%) x 100
L3
Concentration Carry-over
H3 L1 L3 K(%) C(%)
Glucose 20"53 3"83 3.89 -0.3 1.54
(mmol/1)
Urea 23"00 3"89 3.74 0.79 4.08
(mmol/1)
Creatinine 916"9 79"57 78.’55 0"12 1.30
(mol/1)
Total calcium 3"69 2"12 2"13 -0"90 -0"65
(mmol/1)
Sodium 166"2 111"6 111.7 -0"18 -0"08
(mmol)
Potassium 8"24 3.16 3"16 0"07 0"12
(mmol/1)
Chloride 122" 86"23 86" 15 0"20 0"08
(mmol/1)
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Table 3. Method comparison: Passing-Bablok regression.
Range (r) b (i.c. 95%) a (i.c. 95%)
Glucose 4.0-17"3
(mmol/1)
Urea 2"9-31 "0
(mmol/1)
Creatinine 52"0-678"0
(tmol/1)
Total calcium 1.7-2"6
(mmol/1)
Sodium 125-149
(mmol)
Potassium 2"3-5"6
(mmol/1)
Chloride 95-119
(mmol/1)
0"995 1"02 -0"12
(1"00, 1"06) (-0"37, 0"00)
0"995 1"01 -0"36
(0"95, 1"06) (-0"87, 0"033)
0"998 1"00 15"8*
(0"97, 1.04) (-20"9, 11"2)
0"940 0"76* 0’36*
(0"70), 0"84) (0"16, 0"51)
0"777 1"00 4"00
(0"83, 1’33) (-41"3, 26"5)
0"887 1"02 0"24
((0"88, 1"10) (-0"09, 0"81)
0"753 1"00 2’00
(0.80, .) (-.0, .)
* Differences (p < 0"05) constant (A), proportional (B); N 40.
Sample dilution system
A single analyte was used to check the correct perfor-
mance of the automatic sample dilution system: creati-
nine. There were no statistically significant differences
between automatic and manual dilution (t 0’62; g. 1.
19; Pbilat 0"540).
Interferences
The cut-off point in determining the interference level
was fixed for each parameter according to the values
reported in the protocol of the Socitfi Franaise de
Biologie Clinique [3]. Results are expressed in the figures
as percentages. Haemoglobin produced a negative inter-
ference with sodium ([Hb] -> 15 mol/1) and chloride
([Hb] -> 50 tmol/1) (see figure 1).
Turbidity caused by triglycerides (TG) produced a
negative interference with sodium ([TG] >- 2"9 mmol/1,
chloride ([TG] >- 3"1 mmol/1), potassium ([TG] -> 3"0
mmol/1), total calcium ([TG] -> 3"5 mmol/1); a positive
interference with glucose ([TG] -> 5"1 mmol/1) was also
shown by turbidity (figure 2).
Bilirubin (BR) showed a negative interference with
sodium ([BR] -> 60 tmol/1), chloride ([BR] -> 60 mol/1
and creatinine ([BR] >- 200 mol/1 (figure 3).
Table 4. Drift.
After
calibration 12 h % drift
Sodium (mmol/1) 139"0 138"7 -0:22
Potassium (mmol/1) 4"05 4" 13 1"98
Chloride (mmol/1) 105 107 1"91
Glucose (mmol/1) 4"4 4"5 2"27
Urea (mmol/1) 4"7 4"9 4"26
Creatinine (tmol/1) 87 88 1" 15
Total calcium 2"40 2"42 0"83
(mmol/1)
N--3.
Table 5. Linearity.
Supplier’s Tested
Test range range
Sodium (mmol/1) 100-180 80-160
Potassium (mmol/1) 1-9 1"5-9
Chloride (mmol/1) 70-130 60-130
Glucose (mmol/1) 0"5-25 0"5-25
Urea (mmol/1) 0"8-16 1-30
Creatinine (mol/1) 0-1760 10-1700
Total Calcium 1"25-3"75 1"04-3"75
(mmol/1)
Practicability
Environmentalfactors
The IL-Phoenix can be placed on a work table; it
produces little noise and operates at room temperature.
Buffers and reagents are stored at room temperature. It
uses approximately of distilled water as a diluent for
every 100 samples. The waste receptacle supplied does
not have the capacity for the expected output of the
analyser, although a larger one is available. No special
conditions of humidity or electrical installation are
required.
Operator training
For routine work, operator training is easy. The IL-
Phoenix has a simple information program. The oper-
ator’s guide is clear.
Table 6. Detection limit.
x S x+ 2S
Glucose (mmol/1) 0" 14 0" 11 0"36
Urea (mmol/1) 0"45 0"07 0"59
Creatinine (mol/1) 3’75 3"98 11"71
N 30; risk a 5%.
130F. Masi et al. Evaluation of the IL-Phoenix Chemistry/Electrolyte Analyser
%
oo:
OIJT OFF POINTS
g7,5 Na 98%
CI 97%
0 50 100 150 200 250
hemoglobin (t.tmol/L)
7O
0 100 200 300 400 600 600
bilirubin (lamol/L)
700
---+- Na CI
Figure 1. Interferences: haemoglobin.
Flexibility
The system is closed and the customer has to rely
completely on the manufacturer. The methodologies
cannot be modified. A bidirectional on-line connection is
available.
Work conditions
The starting delay is 20 minutes (for calibration). The
highest work speed is one sample every 55 s. The work is
organized sequentially; however, it is possible to process
%
12o
110
100
90
80
CUT OF F POI NTS --
Na 98% K 96%
OI 97% glu 109%
Ca 96%
70
0 2 4 6 8
triglycerides (mmol/L)
Na K CI
Figure 2. Interferences: triglycerides.
glu Ca
10
Na CI --
crea
Figure 3. Interferences: bilirubin.
stat samples without interfering with the routine run.
Neither primary blood sample tubes, nor bar-coded
labels can be used. It is always possible to stop a routine
run, but the analyser will complete the assay of the three
following samples.
Performance controls
The IL-Phoenix is equipped with an alarm system that
detects the buffer and reagent levels. It is possible to
check the reaction temperatures and the motor or valves
performance. The analyser is equipped with acoustic and
screen alarms.
Maintenance
Maintenance operation is short and simple: 20 min
weekly and 40 min monthly.
Computer capabilities and reporting results
The IL-Phoenix can report results in different formats. It
is possible to get a new report of an old sample. Results
are stored on a 31/2 in. diskette.
Quality control
The quality control system is able to use Westgard rules
and Levy-Jennings charts.
Conclusions
In routine conditions, within-run imprecision was good;
between-run imprecision was acceptable. All the coef-
ficients of variation were lower than 5% (except 6% for
urea at low concentrations).
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The relative inaccuracy study reflects a good agreement
with the comparison instrument, except for chloride (r
0"753) and sodium (r 0"777); proportional and constant
differences (p < 0"05) have been shown for total calcium
according to a Passing-Bablok regression.
No sample-related carry-over was found in the assayed
analytes: values obtained are less than 2%. Drift was
negligible; linearity agreed with the information provided
by the supplier. Inaccuracy and imprecision on the
automatic sample dilution system were good.
The following significant interferences were noted:
(1) Haemoglobin produced negative interferences with
sodium and chloride.
(2) Turbidity interfered negatively with sodium, chlor-
ide, potassium and total calcium, and positively with
glucose.
(3) Bilirubin showed a negative interference with
sodium, chloride and creatinine.
The analyser performed acceptably during the evaluation
study; the practicability of the system was good. Other
tests are needed on the instrument to look at its usefulness
in the emergency area of a laboratory.
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